Hologic
ASPR's IBx Portfolio
Contract 1:
Product: Tests
Description of Project: This investment will enable Hologic, Inc. to expand production capacity for COVID-19 tests in their supplier’s facilities, increasing their production capacity to 13 million COVID-19 tests per month by January 2022.
Unique Impact: This investment will enable Hologic to improve the supply to laboratories across the country in addition to scaling up employment in Hologic supplier facilities and support the demand for COVID-19 testing in the United States.
Base Award Amount: $7,506,725.76
Category: Testing Capacity and Raw Materials
Contract 2:
Product: Tests
Description of Project: This investment will further enable Hologic, Inc. to expand production capacity for COVID-19 tests.
Unique Impact: This investment will enable Hologic to improve the supply to laboratories across the country in addition to scaling up employment in Hologic supplier facilities and support the demand for COVID-19 testing in the United States.
Base Award Amount: $119,426,577.30
Category: Testing Capacity and Raw Materials